TILT Biotherapeutics Ltd
Helsinki, Finland · Science and Engineering
Do you work at TILT Biotherapeutics Ltd?
Claim this profile to manage your company.
Data quality
Complete · Accuracy
#oncolytic viruses
#solid tumors
#cancer
#immunotherapy
#oncoimmunology
#T-cell therapy
#Immune checkpoint inhibitors
TILT Biotherapeutics Ltd is a Science and Engineering company based in Helsinki, Finland, founded in 2013, with 20-30 employees.
Overview
TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses.
Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies.
TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his past findings in the lab, but more importantly in the clinic. The research conducted by TILT alone or in collaboration with some of world’s leading research groups with synergic technologies has generated very excellent results. The lead candidate is a clinical stage TNFα/IL2 armed oncolytic adenovirus (TILT-123 or Ad5/3-E2F-delta24-hTNFα-IRES-hIL2).
Multiple Phase I clinical trials are ongoing.
For contact: BD (at) tiltbio.com
Contact Details
info@tiltbio.com
Helsinki, Finland
Founded
2013
Employees
20-30
Categories
Keywords
#oncolytic viruses
#solid tumors
#cancer
#immunotherapy
#oncoimmunology
#T-cell therapy
#Immune checkpoint inhibitors
Companies teams usually look at after TILT Biotherapeutics Ltd
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.